SIP
ATRC icon

Stoneridge Investment Partners’s AtriCure ATRC Stock Holding History

Stoneridge Investment Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-28,026
Closed -$413K – 257
2014
Q3 		$413K Buy
+28,026
New +$446K 0.06% 187

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stoneridge Investment Partners's ATRC Position: Q4 2014 in Review

Stoneridge Investment Partners sold out of AtriCure (ATRC) in Q4 2014, closing a stake of 28,026 shares — an estimated $413K sold.

Stoneridge Investment Partners first reported a position in ATRC in Q3 2014 and held it in 1 quarter. The position peaked at $413K in Q3 2014. 105 funds tracked by Wall St. Rank hold ATRC as of Q4 2014.

  • Stoneridge Investment Partners reported no remaining AtriCure position as of Q4 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 28,026 AtriCure shares in Q4 2014, an estimated $413K.
  • Stoneridge Investment Partners first reported a position in AtriCure in Q3 2014 and held it in 1 quarter.
  • Stoneridge Investment Partners's AtriCure position peaked at $413K in Q3 2014.
  • 105 funds tracked by Wall St. Rank held AtriCure as of Q4 2014.

Based on Stoneridge Investment Partners's 13F filing for Q4 2014, filed 26 Jan 2015.